Risultati per: Carcinoma ovarico e POCUS. Un caso clinico
Questo è quello che abbiamo trovato per te
Linee guida sul carcinoma ovarico, tubarico e peritoneale primario
Un trapianto di staminali fa regredire il diabete, è il primo caso al mondo
In una donna di 25 anni, ora produce insulina autonomamente
Un trapianto di staminali fa regredire il diabete, è il primo caso al mondo
In una donna di 25 anni, ora produce insulina autonomamente
Un trapianto di staminali fa regredire il diabete, è il primo caso al mondo
In una donna di 25 anni, ora produce insulina autonomamente
Surveillance for hepatocellular carcinoma in cirrhosis: End of monopoly for serum alpha fetoprotein
Renal Cell Carcinoma
This review summarizes the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma.
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma
This JAMA Clinical Guidelines Synopsis summarizes the 2023 American Association for the Study of Liver Diseases practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Revised REACH-B Model for Hepatocellular Carcinoma Risk Prediction in Patients With Chronic Hepatitis B
Annals of Internal Medicine, Ahead of Print.
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
Annals of Internal Medicine, Ahead of Print.
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
Annals of Internal Medicine, Ahead of Print.
Revised REACH-B Model for Hepatocellular Carcinoma Risk Prediction in Patients With Chronic Hepatitis B
Annals of Internal Medicine, Ahead of Print.
Tumore del retto,guarigione in 1 caso su 4 anche senza chirurgia
Preservata l’integrità dell’organo, migliora la qualità di vita
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis
Better surveillance tests for hepatocellular carcinoma (HCC) are needed. The GALAD score [Gender, Age, AFP-L3, AFP, and Des-carboxy-prothrombin] has been shown to have excellent sensitivity and specificity for HCC in phase two studies. We performed a phase three biomarker validation study to compare GALAD with AFP in detecting HCC.
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
New England Journal of Medicine, Ahead of Print.
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
New England Journal of Medicine, Ahead of Print.